Counterpoint Mutual Funds’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-24,086
Closed -$244K 187
2023
Q3
$244K Buy
+24,086
New +$288K 0.2% 21

Other funds holding HCAT

Counterpoint Mutual Funds's HCAT Position: Q4 2023 in Review

Counterpoint Mutual Funds sold out of Health Catalyst (HCAT) in Q4 2023, closing a stake of 24,086 shares — an estimated $244K sold.

Counterpoint Mutual Funds first reported a position in HCAT in Q3 2023 and held it in 1 quarter. The position peaked at $244K in Q3 2023. 167 funds tracked by Wall St. Rank hold HCAT as of Q4 2023.

  • Counterpoint Mutual Funds reported no remaining Health Catalyst position as of Q4 2023 after selling out during the quarter.
  • Counterpoint Mutual Funds sold 24,086 Health Catalyst shares in Q4 2023, an estimated $244K.
  • Counterpoint Mutual Funds first reported a position in Health Catalyst in Q3 2023 and held it in 1 quarter.
  • Counterpoint Mutual Funds's Health Catalyst position peaked at $244K in Q3 2023.
  • 167 funds tracked by Wall St. Rank held Health Catalyst as of Q4 2023.

Based on Counterpoint Mutual Funds's 13F filing for Q4 2023, filed 7 Feb 2024.